Skip to main content
Fig. 1 | Acta Neuropathologica Communications

Fig. 1

From: Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma

Fig. 1

Histopathology and molecular markers in ependymoma. Classic expendymoma WHO grade II (a); anaplastic ependymoma WHO grade III (b); ependymoma with TNC (c) and LAMA2 (d) expression; ependymoma with (e) and without (f) 1q25 gain (1q25 green fluorochrome, 1p36 red fluorochrome); g, h confirmation of iFSIH results by SNP arrays, Circos plots showing gain of chromosome arm 1q (g) and a balanced copy-number profile (h)

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us